Tao Zhang

Dr. Tao Zhang

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
LLLi Liu
Li Liu
XWXiaoyan Wu
Xiaoyan Wu
HXHuihui Xu
Huihui Xu
LYLiming Yu
Liming Yu
XZXinjian Zhang
Xinjian Zhang
YXYONG XU
YONG XU

1 October 2018 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
SZSheng Zeng
Sheng Zeng
XWXiaoyan Wu
Xiaoyan Wu
XCXuyang Chen
Xuyang Chen
HXHuihui Xu
Huihui Xu
TZTao Zhang
Tao Zhang
YXYONG XU
YONG XU

21 October 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
LMLei Mao
Lei Mao
LLLi Liu
Li Liu
TZTianyi Zhang
Tianyi Zhang
XWXiaoyan Wu
Xiaoyan Wu
TZTao Zhang
Tao Zhang
YXYONG XU
YONG XU

1 May 2023 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
QZQianwen Zhao
Qianwen Zhao
TSTinghui Shao
Tinghui Shao
YZYuwen Zhu
Yuwen Zhu
GZGengjie Zong
Gengjie Zong
JZJunjie Zhang
Junjie Zhang
TZTao Zhang
Tao Zhang
Myofibroblasts, characterized by the expression of the matricellular protein periostin (Postn), mediate the profibrogenic response during tissue repair and remodeling. Previous studies have demonstrated that systemic deficiency in myocardin-related transcription factor A (MRTF-A) attenuates renal fibrosis in mice. In the present study, we investigated the myofibroblast-specific role of MRTF-A in renal fibrosis and the underlying mechanism. We report that myofibroblast-specific deletion of MRTF-A, achieved through crossbreeding Mrtfa-flox mice with Postn-CreERT2 mice, led to amelioration of renal fibrosis. RNA-seq identified zinc finger E-Box binding homeobox 1 (Zeb1) as a downstream target of MRTF-A in renal fibroblasts. MRTF-A interacts with TEA domain transcription factor 1 (TEAD1) to bind to the Zeb1 promoter and activate Zeb1 transcription. Zeb1 knockdown retarded the fibroblast–myofibroblast transition (FMyT) in vitro and dampened renal fibrosis in mice. Transcriptomic assays showed that Zeb1 might contribute to FMyT by repressing the transcription of interferon regulatory factor 9 (IRF9). IRF9 knockdown overcame the effect of Zeb1 depletion and promoted FMyT, whereas IRF9 overexpression antagonized TGF-β-induced FMyT. In conclusion, our data unveil a novel MRTF-A–Zeb1–IRF9 axis that can potentially contribute to fibroblast–myofibroblast transition and renal fibrosis. Screening for small-molecule compounds that target this axis may yield therapeutic options for the mollification of renal fibrosis.

27 July 2023 in Medical Science Monitor
Verified
Journal Article
Open access
HMHongzhen Ma
Hongzhen Ma
JZJun Zhou
Jun Zhou
MZMeng Zhang
Meng Zhang
CSChun Shen
Chun Shen
ZJZhifan Jiang
Zhifan Jiang
FGFei Gao
Fei Gao
Background: N-terminal proatrial natriuretic peptide (NT-proBNP) levels are often markedly elevated in patients with chronic kidney disease (CKD). Identifying novel biomarkers is an important step toward effective diagnosis. Interleukin-1 receptor-like 1 (IL1RL1) protein and human/Soluble suppression of tumorigenesis-2 (sST2) are promising biomarkers for heart failure (HF). This study aimed to assess the trend of NT-proBNP and sST2 in chronic kidney disease and their diagnostic value for HF.Material/Methods: This study was carried out on 420 patients who were divided into a no heart failure group (N=182) and a heart failure group (N=238). Spearman correlation analysis was used to test the association of sST2 and NT-proBNP with renal function. The diagnostic value of each biomarker was assessed using receiver operating characteristic (ROC) curves according to 3 different forms: Total group (n=420), non-CKD group (n=217), and CKD group (n=203).Results: A striking correlation between eGFR and NT-proBNP (r=-0.525; P<0.001) seemed to be far stronger than that with sST2 (r=-0.147; P<0.05). The optimum cutoff points for sST2 and NT-proBNP to detect HF were 28.960 ng/mL and 1280 pg/mL, respectively, in total, 28.71 ng/mL and 481 pg/mL, respectively, in non-CKD patients, and 30.55 ng/mL and 3314 pg/mL, respectively, in CKD patients. The combined model of sST2 and NT-proBNP was superior to the model of sST2 or NT-proBNP alone, and the difference was statistically significant (P<0.05).Conclusions: The diagnostic value of sST2 is less affected by decreased renal function. sST2 combined with NT-proBNP may improve the diagnostic accuracy of HF.

20 January 2023 in Life Sciences
Verified
Journal Article
Closed access
XWXiaoyan Wu
Xiaoyan Wu
XMXiulian Miao
Xiulian Miao
YGYan Guo
Yan Guo
TSTinghui Shao
Tinghui Shao
STShifan Tang
Shifan Tang
TZTao Zhang
Tao Zhang